What is Robigo?
Founded in 2021, Robigo operates at the intersection of synthetic biology and data science. The company has developed a sophisticated microbial platform designed to address the critical challenges of agricultural disease management. By leveraging advanced bioengineering, Robigo creates targeted solutions that effectively neutralize pathogens while maintaining the integrity of beneficial microorganisms, pollinators, and the broader ecosystem. This dual-focus on efficacy and environmental stewardship places the company at the forefront of the sustainable agriculture movement, providing a scalable alternative to traditional chemical-based pesticides. As the industry shifts toward more precise, biological-based inputs, Robigo's technology serves as a foundational pillar for the next generation of agricultural productivity.
How much funding has Robigo raised?
Robigo has raised a total of $6.8M across 1 funding round:
Angel/Seed
$6.8M
Angel/Seed (2023): $6.9M with participation from Good Growth Capital, First Star Ventures, and Congruent Ventures
Key Investors in Robigo
Good Growth Capital
Good Growth Capital is an early-stage venture capital firm specializing in transformative science and technology investments, with a focus on life sciences and green technology.
First Star Ventures
First Star Ventures supports visionary, technical founders building advanced technologies, with a specific emphasis on techbio and edge computing.
Congruent Ventures
Congruent Ventures is a climate-focused investment firm that partners with early-stage companies to drive innovation in sustainability and carbon reduction.
What's next for Robigo?
The infusion of capital from this latest round will be instrumental in scaling Robigo's research and development operations. Moving forward, the company is expected to focus on the commercial validation of its microbial candidates and the expansion of its data science infrastructure. By deepening its technical capabilities, Robigo aims to transition from its current development phase toward broader field trials and eventual market entry. The strategic backing from climate-focused and tech-bio investors suggests a long-term roadmap centered on sustainable growth and the establishment of a dominant position within the precision agriculture market. As the firm continues to refine its platform, it remains a key entity to watch for those tracking the evolution of bio-industrial applications in global food systems.
See full Robigo company page
